This tetramer assay revealed a significant difference in the OVA‐tetramer+ CD8+ T cell population, which showed an increase in the percentage of tumor antigen‐specific CD8+ T cells in AI‐TEV‐injected mice. The gene discussed is CD8A; the disease is neoplasm.